Table 4.
Demographic and laboratory characteristics of the outpatient and hospitalized COVID‐19 patients
| Variables | Confirmed COVID‐19 outpatients | Confirmed COVID‐19 hospitalized patients | p Value |
|---|---|---|---|
| Patients, n | 196 | 55 | |
| Age, years, (mean ± SD) | 8.92 ± 6.01 | 3.60 ± 4.51 | .198 |
| Gender, male, n (%) | 109 (55.6) | 30 (54.5) | .888 |
| Laboratory findings | |||
| MPV (mean ± SD), fL | 9.65 ± 1.02 | 10.1 ± 1.04 | .011 |
| PLT (mean ± SD)/mm3 | 260,909 ± 60,609 | 304,333 ± 87,572 | .777 |
| WBC (mean ± SD)/mm3 | 7150 ± 2389 | 12,741 ± 6836 | .004 |
| ANC (mean ± SD)/mm3 | 3807 ± 2024 | 8277 ± 6851 | .060 |
| ALC (mean ± SD)/mm3 | 2366 ± 1318 | 3246 ± 2860 | .878 |
| Hb (mean ± SD), g/dl | 12.9 ± 1.34 | 12.1 ± 2.17 | .017 |
| CRP (mean ± SD), mg/L | 8.5 ± 6.6 | 49.8 ± 59.4 | .003 |
| Procalcitonin (mean ± SD), µg/L | 0.09 ± 0.02 | 1.52 ± 2.91 | <.001 |
| D‐dimer (mean ± SD), µg/L | 601 ± 304.8 | 2197 ± 1471.1 | <.001 |
| Fibrinogen (mean ± SD), mg/dl | 325.6 ± 71.1 | 377.9 ± 161.3 | .125 |
| NT‐pro‐BNP (mean ± SD), ng/L | 43.9 ± 52.3 | 388.5 ± 583.9 | <.001 |
| Lymphopenia n (%) | 50 (25.5) | 15 (27.3) | .792 |
| (<1500/mm3) | |||
| Neutropenia, n (%) | 28 (14.3) | 8 (14.5) | .961 |
| (<1500/mm3) | |||
| Thrombocytopenia, n (%) | 4 (2) | 7 (12.7) | .003 |
| (<150,000/mm3) | |||
| NLR (mean ± SD) | 2.23 ± 1.74 | 6.98 ± 8.07 | .274 |
Note: The bold values indicate statistical analysis differences and correlations were considered significant at p < .05.
Abbreviations: ALC, absolute lymphocyte count; ANC, absolute neutrophil count; COVID‐19, coronavirus disease 2019; CRP, C‐reactive protein; Hb, Hemoglobin; MPV, mean platelet volume; NLR, neutrophil‐to‐lymphocyte ratio; NT‐pro‐BNP, N‐terminal‐pro‐brain natriuretic peptide; PCT, procalcitonin; PLT, platelet count; WBC, white blood cell.